Vaccine developments improve sentiment
- November 16, 2020
Balance Sheet Risk Management
Financial Institutions | Kennett Square, PA
SummaryThe major U.S. equity indices ended the week mixed with the Dow Jones Industrial Average and the S&P 500 moving higher and the Nasdaq heading lower amid rapidly rising COVID-19 cases in the U.S., mixed economic data updates, and encouraging COVID-19 vaccine developments.
Prior week summary
The major U.S. equity indices ended the week mixed with the Dow Jones Industrial Average and the S&P 500 moving higher and the Nasdaq heading lower amid rapidly rising COVID-19 cases in the U.S., mixed economic data updates, and encouraging COVID-19 vaccine developments. As of Sunday evening, the global tally of COVID-19 cases sits just below 55 million with over 20% of the cases originating in the U.S. The U.S. has seen a rapid rise in COVID-19 cases and hospitalizations in the last month. On Friday, the U.S. reported over 184,000 new cases of COVID-19, marking the fourth consecutive day that the daily case count set a record and tallying a seven-day moving average above 150,000 cases for the first time during the pandemic. As cases surge around the country, many state and local governments have re-imposed restrictions, including New York, which now requires bars and restaurants to close at 10pm. In Europe, COVID-19 infection rates have also been on the rise with several countries, including France, Germany, and the U.K., issuing significant restrictions on social activity and travel in recent weeks. After French President Emmanuel Macron announced a second lockdown two weeks ago, French Prime Minister Jean Castex announced on Thursday that there will be no changes to the guidance for at least the next two weeks as the country works to get the virus under control so they can, “allow a new easing of rules at the time of the Christmas holidays.”
Market participants were delighted at the start of the week when Pfizer and BioNTech announced that an interim analysis of an ongoing clinical trial on its prospective vaccine showed that the vaccine was more than 90% effective in preventing COVID-19 contraction, sending equities and yields higher and improving investor sentiment. While the preliminary trial results are highly encouraging, Pfizer will need at least two months of follow-up data from volunteers, expected to be available later this month, before the company can begin to seek approval from the Food and Drug Administration to distribute the vaccine. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, emphasized the importance of widespread vaccine adoption saying, “We’ve got to convince people to take the vaccine, because if you have a highly effective vaccine and only 50% of the people take it, you’re not going to have the impact that you’d need to essentially bring the pandemic down to such a low level that it’s no longer threatening society. And that’s the goal of a vaccine.”
In a light week for economic data releases, market participants digested updated figures on inflation and jobless claims. Thursday’s release of the Consumer Price Index (CPI) indicated that prices remained unchanged over the last month, falling below expectations for a 0.1% increase. Inflation continues to trend lower, with prices rising 1.2% year over year as measured by the CPI, much lower than the 2.3% pace seen before the pandemic. Wholesale prices rose more than expected in October, increasing 0.3% according to the Producer Price Index but below the 0.4% pace seen in September. 709,000 individuals filed for unemployment in the last week, the lowest level seen during the pandemic but above any level seen in the country before this year. Analysts warn that the trend lower in jobless claims may reverse as the U.S. grapples with a surge in COVID-19 cases. Continuing jobless claims also fell week over week to 6.79 million. Federal Reserve Chair Jerome Powell spoke at the European Central Bank’s Forum on Central Banking on Thursday. In his remarks, Powell expressed optimism about the recent progress in vaccine developments saying that it, “is good and welcome news to the medium term,” but cautioned, “It’s just too soon to assess with any confidence the implications of the news for the path of the economy, especially in the near term.”
The look forward
Market participants are gearing up for a busy week of economic data releases with updates on the Empire Manufacturing Index, retail sales, industrial production, housing starts, building permits, jobless claims, existing home sales, and the Philadelphia Fed Business Outlook Survey, among others, dotting the economic calendar.
Market implied policy path (Overnight indexed swap rates)
Chatham Hedging Advisors, LLC (CHA) is a subsidiary of Chatham Financial Corp. and provides hedge advisory, accounting and execution services related to swap transactions in the United States. CHA is registered with the Commodity Futures Trading Commission (CFTC) as a commodity trading advisor and is a member of the National Futures Association (NFA); however, neither the CFTC nor the NFA have passed upon the merits of participating in any advisory services offered by CHA. For further information, please visit chathamfinancial.com/legal-notices.
Transactions in over-the-counter derivatives (or “swaps”) have significant risks, including, but not limited to, substantial risk of loss. You should consult your own business, legal, tax and accounting advisers with respect to proposed swap transaction and you should refrain from entering into any swap transaction unless you have fully understood the terms and risks of the transaction, including the extent of your potential risk of loss. This material has been prepared by a sales or trading employee or agent of Chatham Hedging Advisors and could be deemed a solicitation for entering into a derivatives transaction. This material is not a research report prepared by Chatham Hedging Advisors. If you are not an experienced user of the derivatives markets, capable of making independent trading decisions, then you should not rely solely on this communication in making trading decisions. All rights reserved.20-0444
Our featured insights
Perspectives on ESG in commercial and multifamily real estate
We are often asked what we are seeing with respect to ESG terms or provisions in financings, derivatives, investment vehicle structures, etc. While a tremendous amount of attention is being allocated to ESG broadly across the global real estate markets, there is a wide variance of approaches,...
Big banks report strong Q3 earnings
Building on the previous week’s gains, the major U.S. equity indices finished the week in the green, while short and mid-term Treasury yields moved notably higher as investors digested the latest economic data releases, the minutes from the latest FOMC meeting, and Q3 earnings releases.
Long-term yields continue march higher
After falling substantially in the final week of the third quarter, the major U.S. equity indices started the fourth quarter on solid footing, each moving higher last week, while long-term Treasury yields continued their march higher, as investors digested mixed economic data releases, primarily...
Is the inflation story over-inflated, and what does it mean for interest rates?
The global inflation story has captured the headlines as we emerged from COVID-19 lockdowns and economies reopened. There are different measures of inflation, showing different trends over different measurement periods. This piece considers the key market inflation measures and discusses how this...
Hawkish FOMC meeting sends yields higher
In yet another eventful week, the major U.S. equity indices ended flat to modestly higher while Treasury yields saw significant increases on the back of strong economic data and a hawkish FOMC meeting.
Debt ceiling talks take center stage in Washington
The major U.S. equity indices moved lower for the second consecutive week and long-term Treasury yields increased modestly as market participants digested the latest inflation readings, political wrangling on Capitol Hill, and the continued spread of the COVID-19 delta variant.
U.S. real estate and capital markets update Q3 2021
As we wind down on summer 2021, many Americans are returning to the office and sending their children back to school. We recently reviewed the effects of COVID-19 on the U.S. economy and takeaways for the real estate market during our semiannual market update webinar. On September 15,...
European real estate and capital markets update Q3 2021
It’s back-to-school month for most children, and back to the office for an increasing number of workers too. What better time to host our semiannual market update webinar for real estate? On 15 September, participants listened to our experts, Adrian Ng and Jamie Macdonald, provide an overview of...